Ajanta Pharma Q2 Results

Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period

Updated On: 05 Nov 2019 | 8:38 PM IST

Shares of Ajanta Pharma were today trading at Rs 1,250.10 per scrip, up 1.37 per cent, on BSE

Updated On: 31 Oct 2017 | 2:45 PM IST